ED patients with acute migraine will be randomized to either prochlorperazine and Bendaryl
OR imitrex. VAS for pain will be monitored, along with side effects. Primary outcome measure
is improvement in pain scales between the groups.
- Acute migraine headache
- Chest pain
- < 18
- Allergy to any of the meds